Effect of sesquiterpene lactone coronopilin on leukaemia cell population growth, cell type-specific induction of apoptosis and mitotic catastrophe

Cell Proliferation

Volumn 45, Issue 1, 2012, Pages 53-65

  Cotugno, R ^a   Fortunato, R ^a   Santoro, A ^a   Gallotta, D ^a   Braca, A ^b   de Tommasi, N ^a   Belisario, M A ^a  

^a UNIVERSITY OF SALERNO   (Italy)

^b UNIVERSITY OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE; CORONOPILIN; CYCLIN B1; CYCLIN DEPENDENT KINASE 1; HISTONE H3; SESQUITERPENE LACTONE DERIVATIVE; TUBULIN; UNCLASSIFIED DRUG;

AMBROSIA ARBORESCENS; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE PROGRESSION; CELL GROWTH; CELL POPULATION; CELL STRAIN U937; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; HUMAN; HUMAN CELL; IC 50; LEUKEMIA CELL LINE; LEUKOCYTE; MITOSIS INDEX; PROTEIN EXPRESSION; RAGWEED;

AMBROSIA; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CASPASES; CELL CYCLE CHECKPOINTS; CELL PROLIFERATION; DNA DAMAGE; DRUG DISCOVERY; HUMANS; JURKAT CELLS; LEUKEMIA; MITOSIS; PHYTOTHERAPY; PLANTS, MEDICINAL; SESQUITERPENES; TUBULIN; U937 CELLS;

AMBROSIA;

EID: 84655169604     PISSN: 09607722     EISSN: 13652184     Source Type: Journal    
DOI: 10.1111/j.1365-2184.2011.00796.x     Document Type: Article

References (54)

1. Newman DJ, Cragg GM, Snader KM (2003) Natural products as sources of new drugs over the period 1981-2002. J. Nat. Prod. 66, 1022-1037.
2. Zhang S, Won Y-K, Ong C-N, Shen H-M (2005) Anti-cancer potential of sesquiterpene lactones: bioactivity and molecular mechanisms. Anticancer Agents 5, 239-249.
3. Liu JW, Cai MX, Xin Y, Wu QS, Ma J, Yang P et al. (2010) Parthenolide induces proliferation inhibition and apoptosis of pancreatic cancer cells in vitro. J. Exp. Clin. Canc. Res. 29, 108.
4. Kupchan SM, Fessler DC, Eakin MA, Giacobbe TJ (1970) Reactions of α methylene lactone tumor inhibitors with model biological nucleophils. Science 168, 376-378.
5. Avonto A, Taglialatela-Scafati O, Pollastro F, Minassi A, Di Marzo V, De Petrocellis L et al. (2011) An NMR Spectroscopic method to identify and classify thiol-trapping agents: revival of Michael acceptors for drug discovery. Angew. Chem. Int. Ed. 50, 467-471.
6. Fernandes MB, Scotti MT, Ferreira MJP, Emerenciano VP (2008) Use of self-organizing maps and molecular descriptors to predict the cytotoxic activity of sesquiterpene lactones. Eur. J. Med. 43, 2197-2205.
7. Ghantous A, Gali-Muhtasib H, Vuorela H, Saliba NA, Darwiche N (2010) What made sesquiterpene lactones reach cancer clinical trials? Drug Discov. Today 15, 668-678.
8. Scotti MT, Fernandes MB, Ferreira MJP, Emerenciano VP (2007) Quantitative structure-activity relationship of sesquiterpene lactones with cytotoxic activity. Bioorg. Med. Chem. 15, 2927-2934.
9. De Leo M, Vera Saltos MB, Naranjo Puente BF, De Tommasi N, Braca A (2010) Sesquiterpenes and diterpenes from Ambrosia arborescens. Phytochemistry 71, 804-809.
10. De Leo M, Vera Saltos MB, Naranjo Puente BF, De Tommasi N, Braca A (2011) Corrigendum to "Sesquiterpenes and diterpenes from Ambrosia arborescens" [Phytochemistry 71 (2010) 804-809]. Phytochemistry 72, 952.
11. Correa QJE, Bernal HY (1990) Especies promisorias vegetales de los países del Convenio Andrés Bello, Tomo V. Bogotá: SECAB Ciencia y Tecnología 17, pp. 464-467.
12. Duval M, Klein JP, He W, Cahn JY, Cairo M, Camitta BM et al. (2010) Hematopoietic stem-cell transplantation for acute leukemia in relapse or primary induction failure. J. Clin. Oncol. 28, 3730-3738.
13. Ofran Y, Rowe JM (2011) Induction and postremission strategies in acute myeloid leukemia: what is new? Curr. Opin. Hematol. 18, 83-88.
14. Nicoletti I, Migliorati G, Pagliacci MC, Grignani F, Riccardi C (1991) A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J. Immunol. Methods 139, 271-279.
15. Santoro A, Pisanti S, Grimaldi C, Izzo AA, Borrelli F, Proto MC et al. (2009) Rimonabant inhibits human colon cancer cell growth and reduces the formation of precancerous lesions in the mouse colon. Int. J. Cancer 125, 996-1003.
16. Gallotta D, Nigro P, Cotugno R, Gazzerro P, Bifulco M, Belisario MA (2010) Rimonabant-induced apoptosis in leukemia cell lines: activation of caspase-dependent and -independent pathways. Biochem. Pharmacol. 80, 370-380.
17. Wu Y-C, Yen W-Y, Ho H-Y, Su T-L, Yi L-H (2010) Glyfoline induces mitotic catastrophe and apoptosis in cancer cells. Int. J. Cancer 126, 1017-1028.
18. Ly JD, Grubb DR, Lawen A (2003) The mitochondrial membrane potential (deltapsi(m)) in apoptosis; an update. Apoptosis 8, 115-128.
19. Vandenabeele P, Vanden Berghe T, Festjens N (2006) Caspase inhibitors promote alternative cell death pathways. Sci. STKE 358, pe44.
20. Moubarak RS, Yuste VJ, Artus C, Bouharrour A, Greer PA, Menissier-de Murcia J et al. (2007) Sequential activation of poly(ADP-Ribose) polymerase 1, calpains, and bax is essential in apoptosis-inducing factor-mediated programmed necrosis. Mol. Cell. Biol. 27, 4844-4862.
21. Vakifahmetoglu H, Olsson M, Zhivotovsky B (2008) Death through a tragedy: mitotic catastrophe. Cell Death Differ. 15, 1153-1162.
22. Morgan DO (1995) Principles of CDK regulation. Nature 374, 131-134.
23. 2 and spreads in an ordered fashion coincident with mitotic chromosome condensation. Chromosoma 106, 348-360.
24. Murnion ME, Adams RR, Callister DM, Allis CD, Earnshaw WC, Swedlow JR (2001) Chromatin-associated protein phosphatase 1 regulates aurora-B and histone H3 phosphorylation. J. Biol. Chem. 276, 26656-26665.
25. Song L, Li D, Liu R, Zhou H, Chen J, Huang X (2007) Ser-10 phosphorylated histone H3 is involved in cytokinesis as a chromosomal passenger. Cell Biol. Int. 31, 1184-1190.
26. Bonner WM, Redon CE, Dickey JS, Nakamura AJ, Sedelnikova OA, Solier S et al. (2008) GammaH2AX and cancer. Nat. Rev. Cancer 8, 957-967.
27. Kroemer G, Galluzzi L, Brenner C (2007) Mitochondrial membrane permeabilization in cell death. Physiol. Rev. 87, 99-163.
28. Nigg EA (2001) Mitotic kinases as regulators of cell division and its checkpoints. Nat. Rev. Mol. Cell Biol. 2, 21-32.
29. Carmena M, Ruchaud S, Earnshaw WC (2009) Making the Auroras glow: regulation of Aurora A and B kinase function by interacting proteins. Curr. Opin. Cell Biol. 21, 796-805.
30. 2/M transition. J. Biol. Chem. 285, 16978-16990.
31. Brandeis M, Hunt T (1996) The proteolysis of mitotic cyclins in mammalian cells persists from the end of mitosis until the onset of S phase. EMBO J. 15, 5280-5289.
32. Hans F, Dimitrov S (2001) Histone H3 phosphorylation and cell division. Oncogene 20, 3021-3027.
33. Jackson JR, Patrick DR, Dar MM, Huang PS (2007) Targeted anti-mitotic therapies: can we improve on tubulin agents? Nat. Rev. Cancer 7, 107-117.
34. Gascoigne KE, Taylor SS (2009) How do anti-mitotic drugs kill cancer cells? J. Cell Sci. 122, 2579-2585.
35. Oakley BR (2000) An abundance of tubulins. Trends Cell Biol. 10, 537-542.
36. Legault J, Gaulin J-F, Mounetou E, Bolduc S, Lacroix J, Poyet P et al. (2000) Microtubule disruption induced in vivo by alkylation of β-tubulin by 1-aryl-3-(2-chloroethyl)ureas, a novel class of soft alkylating agents1. Cancer Res. 60, 985-992.
37. Stewart BJ, Doorn JA, Petersen DR (2007) Residue-specific adduction of tubulin by 4-hydroxynonenal and 4-oxononenal causes cross-linking and inhibits polymerization. Chem. Res. Toxicol. 20, 1111-1119.
38. Bocca C, Gabriel L, Bozzo F, Miglietta A (2004) A sesquiterpene lactone, costunolide, interacts with microtubule protein and inhibits the growth of MCF-7 cells. Chem. Biol. Interact. 147, 79-86.
39. Miglietta A, Bozzo F, Gabriel L, Bocca C (2004) Microtubule-interfering activity of parthenolide. Chem. Biol. Interact. 149, 165-173.
40. 2/M phase arrest, endoreduplication, and delayed apoptosis. Exp. Mol. Med. 41, 665-677.
41. Castedo M, Perfettini J-L, Roumier T, Valent A, Raslova H, Yakushijin K et al. (2004) Mitotic catastrophe constitutes a special case of apoptosis whose suppression entails aneuploidy. Oncogene 23, 4362-4370.
42. Mansilla S, Priebe W, Portugal J (2006) Mitotic catastrophe results in cell death by caspase-dependent and caspase-independent mechanisms. Cell Cycle 5, 53-60.
43. Ichijima Y, Sakasai R, Okita N, Asahina K, Mizutani S, Teraoka H (2005) Phosphorylation of histone H2AX at M phase in human cells without DNA damage response. Biochem. Biophys. Res. Commun. 336, 807-812.
44. Kaufman PA, Weinberg JB, Greene WC (1992) Nuclear expression of the 50- and 65-kD Rel related subunits of nuclear factor-κB is differentially regulated in human monocytic cells. J. Clin. Invest. 90, 121-129.
45. Chan AC, van Oers NSC, Tran A, Turka L, Law CL, Ryan JC et al. (1994) Differential expression of ZAP-70 and Syk protein tyrosine kinases, and the role of this family of protein tyrosine kinases in TCR signaling. J. Immunol. 152, 4758-4766.
46. Alvarez P, Sáenz P, Arteta D, Martínez A, Pocoví M, Simón L et al. (2007) Transcriptional profiling of hematologic malignancies with a low-density DNA microarray. Clin. Chem. 53, 259-267.
47. Steele AJ, Jones DT, Ganeshaguru K, Duke VM, Yogashangary BC, North JM et al. (2006) The sesquiterpene lactone parthenolide induces selective apoptosis of B-chronic lymphocytic leukemia cells in vitro. Leukemia 20, 1073-1079.
48. Mariani AR, Columbaro M, Zauli G, Zamai L, Luchetti F, Gobbi P et al. (1999) Lineage-related susceptibility of human hemopoietic cell lines to apoptosis. Anat. Rec. 254, 1-6.
49. Bernabei P, Coccia EM, Rigamonti L, Bosticardo M, Forni G, Pestka S et al. (2001) Interferon-γ receptor 2 expression as the deciding factor in human T, B, and myeloid cell proliferation or death. J. Leuk. Biol. 70, 959-960.
50. Wuchter C, Ruppert V, Schrappe M, Dörken B, Ludwig WD, Karawajew L (2002) In vitro susceptibility to dexamethasone- and doxorubicin-induced apoptotic cell death in context of maturation stage, responsiveness to interleukin 7, and early cytoreduction in vivo in childhood T-cell acute lymphoblastic leukemia. Blood 99, 4109-4115.
51. Nagai F, Hiyoshi Y, Sugimachi K, Tamura HO (2002) Cytochrome P450 (CYP) expression in human myeloblastic and lymphoid cell lines. Biol. Pharm. Bull. 25, 383-385.
52. Kamau SW, Krämer SD, Günthert M, Wunderli-Allenspach H (2005) Effect of the modulation of the membrane lipid composition on the localization and function of P-glycoprotein in MDR1-MDCK cells. In Vitro Cell. Dev. Biol. Anim. 41, 207-216.
53. Yeung TK, Germond C, Chen X, Wang Z (1999) The mode of action of taxol: apoptosis at low concentration and necrosis at high concentration. Biochem. Biophys. Res. Commun. 263, 398-404.
54. Schmit TL, Ahmad N (2007) Regulation of mitosis via mitotic kinases: new opportunities for cancer management. Mol. Cancer Ther. 6, 1920-1931.